AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Silence Therapeutics plc

Net Asset Value Jul 3, 2013

33536_rns_2013-07-03_32542b7b-2289-4cb1-a01f-7c6bec75c404.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4539I

Silence Therapeutics PLC

03 July 2013

Silence Therapeutics plc ("Silence" or the "Company")

CANCELLATION OF WARRANTS

03 July 2013

The Company has agreed to buy back and cancel the 66,600 warrants, exercisable at 75p,  issued to Darwin Strategic Ltd for a payment of £70,000. This was the fair value of the warrants on 4 June 2013, the date Silence published its annual report. Darwin is 37% owned by Ali Mortazavi, the chief executive of Silence.

For further information please contact:

Silence Therapeutics

Ali Mortazavi, chief executive/Timothy Freeborn, finance director +44 (0)333 988 0140

[email protected]

[email protected]

N+1 Singer

Shaun Dobson/Jenny Wyllie

+44 20 7496 3000

[email protected]

[email protected]

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFVRDEIFIIV

Talk to a Data Expert

Have a question? We'll get back to you promptly.